Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Macro Group Pharmaceuticals (Macro Capital) Co ROE % Adjusted to Book Value Chart
Macro Group Pharmaceuticals (Macro Capital) Co Annual Data
Trend
Dec20
Dec21
Dec22
ROE % Adjusted to Book Value
0.00
0.00
10.36
Macro Group Pharmaceuticals (Macro Capital) Co Quarterly Data
CAI:MCRO vs PG, CL, KVUE: ROE % Adjusted to Book Value Comparison
For the Household & Personal Products subindustry, Macro Group Pharmaceuticals (Macro Capital) Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Macro Group Pharmaceuticals (Macro Capital) Co ROE % Adjusted to Book Value vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Macro Group Pharmaceuticals (Macro Capital) Co's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Macro Group Pharmaceuticals (Macro Capital) Co's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of 4.66% mean?
Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) has a ROE % Adjusted to Book Value of 4.66% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Macro Group Pharmaceuticals (Macro Capital) Co and its competitors.
Is Macro Group Pharmaceuticals (Macro Capital) Co's ROE % Adjusted to Book Value too high?
Macro Group Pharmaceuticals (Macro Capital) Co's current ROE % Adjusted to Book Value is 4.66%. Overall, Macro Group Pharmaceuticals (Macro Capital) Co has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Macro Group Pharmaceuticals (Macro Capital) Co's ROE % Adjusted to Book Value compare to PG and CL?
Macro Group Pharmaceuticals (Macro Capital) Co's ROE % Adjusted to Book Value of 4.66% can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Consumer Packaged Goods company?
A good ROE % Adjusted to Book Value depends on the Consumer Packaged Goods industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Macro Group Pharmaceuticals (Macro Capital) Co and its competitors. Macro Group Pharmaceuticals (Macro Capital) Co's current ROE % Adjusted to Book Value is 4.66%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Macro Group Pharmaceuticals (Macro Capital) Co stock overvalued right now?
Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO) has a current ROE % Adjusted to Book Value of 4.66%. The current ROE % Adjusted to Book Value is 4.66%. Macro Group Pharmaceuticals (Macro Capital) Co's overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Macro Group Pharmaceuticals (Macro Capital) Co (CAI:MCRO), the current ROE % Adjusted to Book Value is 4.66% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Macro Group Pharmaceuticals (Macro Capital) Co is principally engaged in the manufacture and sale of cosmeceutical and ventured into nutraceutical products.
38GF Score
Get the complete analysis for CAI:MCRO
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CAI:MCRO has been successfully added to your 
